Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
McKinsey
Farmers Insurance
Cantor Fitzgerald
Fish and Richardson
US Army

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 9,700,597

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,700,597
Title:Methods of treating cognitive impairment
Abstract: The subject invention concerns materials and methods for treating a person or animal having cognitive impairment. In one embodiment, the method comprises administering an effective amount of one or more inflammatory mediator(s), for example, fms-related tyrosine kinase 3 (Flt3) ligand, interleukin-6 (IL-6), macrophage migration inhibitory factor (MIF), interleukin-1 (IL-1), interleukin-3 (IL-3), erythropoietin (EPO), vascular endothelial growth factor A (VEGF-A), hypoxia-inducible transcription factor (HIF-1alpha), insulin like growth factor-1 (IGF-1), tumor necrosis factor (TNF), granulocyte colony-stimulating factor (G-CSF), granulocyte/macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), Stem Cell Factor (SCF), Darbepoetin (ARANESP), and metalloproteinases, to an animal or person in need of treatment.
Inventor(s): Potter; Huntington (Denver, CO), Boyd; Timothy (Aurora, CO), Jim; Heather Sevey Lawrence (Tampa, FL)
Assignee: UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, FL)
Application Number:14/730,485
Patent Claims:see list of patent claims

Details for Patent 9,700,597

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Sign Up UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, FL) ➤ Sign Up RX Orphan search
Berlex Labs LEUKINE sargramostim VIAL 103362 002 1991-03-05 ➤ Sign Up UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, FL) ➤ Sign Up RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 001 1991-03-05 ➤ Sign Up UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, FL) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Sign Up UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, FL) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 003 1991-02-20 ➤ Sign Up UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, FL) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim VIAL 103353 002 1991-02-20 ➤ Sign Up UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, FL) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20 ➤ Sign Up UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, FL) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,700,597

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Daiichi Sankyo
Accenture
Johnson and Johnson
Argus Health
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.